HISTORY AND IDENTITY
URODELIA is an innovative benchmark company in the field of interactions between calcium phosphates and biotechnology applied to oncology.
Created in 2003 by Nicole Rouquet, Chemist, Patrick Frayssinet, Medical Doctor and Patrick Landanger, Business Angel, URODELIA is dedicated to implementing cancer research programs.
4 KEY DATES :
- 2003: Creation of the company URODELIA SA located in Saint Lys (France).
- 2005: Young Innovative Company Status. Labeling of immunology research program by the Canceropole GSO (National research label). Early clinical trials and first APAVAC patent filing.
- 2008: Opening of a company for the production of Calcium Phosphate powders (hydroxylapatite) at a medical grade for orthopedics application (joint venture).
- 2010: Clinical results of APAVAC in veterinary medicine. Opening up the capital to individual investors.